DMKPQ — DMK Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$6.66m
- $4.76m
Brief: ZMI Pharma Finalized Acquisition Of All Strategic Assets Necessary To Manufacture Zimhi From Dmk Pharma
Brief: DMK Pharmaceuticals Files For Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Dmk Pharmaceuticals Regains Full Rights To Commercialize Zimhi
Brief: DMK Pharmaceuticals Regains Full Rights From US Worldmeds For Symjepi And Provides Corporate Update
Brief: Dmk Pharmaceuticals Corp Received Superseding Notice From Nasdaq, Indicating That The Prior Notice Was Issued In Error
Brief: Dmk Pharmaceuticals Corp - Seth Cohen Is Appointed Chief Financial Officer
Brief: DMK Pharmaceuticals Got Notice From Nasdaq Saying It Is Not In Compliance With Minimum Bid Price Requirements
Brief: Adamis Pharmaceuticals Changes Name To DMK Pharmaceuticals
Adamis Pharmaceuticals shares soar with heavy trading volume
Brief: Adamis Pharmaceuticals To Fund Zimhi Clinical Study With University Of Leiden Expert
Brief: Adamis Pharmaceuticals CFO David C. Benedicto Notified That He Was Tendering His Resignation
Brief: Adamis Pharmaceuticals Corp Files For Offering On A Reasonable Best Efforts Basis Up To 4.65 Million Units - SEC Filing
U.S. STOCKS ON THE MOVE-Copper miners, Benitec Biopharma, SL Green
U.S. STOCKS ON THE MOVE-Wolfspeed, Papa John, Chart Industries
U.S. STOCKS ON THE MOVE-Vertex Energy, Adamis Pharma, Gold miners
Adamis Pharma up on NIH grant for alcohol use disorder treatment
Brief: Adamis Pharmaceuticals Announces NIH Grant Funding For The Treatment Of Alcohol Use Disorder
Brief: Adamis Pharmaceuticals Announces Reverse Stock Split
Brief: Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results And Provides Corporate Update